Scott Leffler is the new Chief Financial Officer of Revance, and Kira Schwartz is the new Chief Legal Officer, effective immediately, the Company announced.
Revance also announced the promotion of Nick Crowe to Chief Operating Officer. They will join Revance’s Executive Leadership Team and report to Nadeem Moiz, Chief Executive Officer.
Mr. Leffler will lead the finance team, overseeing accounting, FP&A, treasury, tax, capital allocation, and risk management. He most recently served as CFO at Myriad Genetics. He also held CFO roles at Clover Health, Sotera Health, and Exal Corporation (now Trivium Packaging).
Ms. Schwartz will lead Revance’s legal and compliance functions, overseeing corporate governance, transactions, dispute resolution, regulatory matters, and intellectual property. She recently served as Executive Vice President, General Counsel, and Corporate Secretary at Odyssey Therapeutics. She previously held senior roles at Prevail Therapeutics, Pfizer, and Cleary Gottlieb Steen & Hamilton LLP.
Mr. Crowe has been with Revance for more than 10 years, most recently as Chief Accounting Officer.
“As we accelerate our pace of growth and transformation across our people, processes, and portfolio of products, we are thrilled to also continue to expand our talented bench of leaders,” says Moiz in a news release. “On behalf of Revance, we welcome Scott and Kira to the team, while recognizing Nick’s well-deserved promotion. Together, they bring deep expertise across finance, legal, and operations that will be instrumental as we advance our market-leading position.”
